Mandragora (mandrake) was described by Theophrastus in the fourth century B.C. for treatment of gout, wounds, and sleeplessness, and as a love potion. By the first century A.D. Dioscorides recognized wine of mandrake as an anaesthetic for treatment of pain or sleeplessness, to be given prior to surgery or cautery. Atropine sulfate anhydrous extracts from the Egyptian henbane were used by Cleopatra in the last century B.C. to dilate her pupils, in the hope that she would appear more alluring. In the Renaissance, women used the juice of the berries of Atropa belladonna to enlarge the pupils of their eyes, for cosmetic reasons; "bella donna" is Italian for "beautiful lady". The mydriatic effects of atropine were studied among others by the German chemist Friedrich Ferdinand Runge (1795–1867). In 1831, the pharmacist Mein succeeded the pure crystalline isolation of atropine. In 1901, the substance was first synthesized by German chemist Richard Willstätter. Atropinic shock therapy is an old and rarely-used method. Atropinic shock treatment is considered safe with careful monitoring and preparation, but it entails prolonged coma and it has many unpleasant side-effects, such as blurred vision.

Atropine sulfate anhydrous(CAS NO.55-48-1) is also named as 1-alpha-H,5-alpha-H-Tropan-3-alpha-ol (+-)-tropate (ester), sulfate (2:1) salt; AI3-14072; Atropen; Atropette; Atropin siran; Atropin siran [Czech]; Atropine sulfate; Atropine sulfate (VAN); Atropine sulphate; Atropine sulphate (VAN); Atropine, sulfate (2:1); Atropinium sulfate; Atropisol; Corbella. Atropine sulfate is a tropane alkaloid extracted from deadly nightshade, jimsonweed , mandrake and other plants of the family Solanaceae. It serves as a drug with a wide variety of effects and is a competitive antagonist for the muscarinic acetylcholine receptor.  Atropine sulfate anhydrous can be synthesized by the reaction of tropine with tropic acid in the presence of hydrochloric acid.Atropine is a racemic mixture of D-hyoscyamine and L-hyoscyamine, with most of its physiological effects due to L-hyoscyamine. Its pharmacological effects are due to binding to muscarinic acetylcholine receptors. It is an antimuscarinic agent. Atropine sulfate anhydrous is used as a cycloplegic, to temporarily paralyze the accommodation reflex, and as a mydriatic, to dilate the pupils.

Physical properties about Atropine sulfate anhydrous are: (1)ACD/LogP: 1.528; (2)ACD/LogD (pH 5.5): -1.55; (3)ACD/LogD (pH 7.4): -0.94; (4)ACD/BCF (pH 5.5): 1.00; (5)ACD/BCF (pH 7.4): 1.00; (6)ACD/KOC (pH 5.5): 1.00; (7)ACD/KOC (pH 7.4): 1.00; (8)#H bond acceptors: 4; (9)#H bond donors: 1; (10)Flash Point: 213.7 °C; (11)Enthalpy of Vaporization: 72.22 kJ/mol; (12)Boiling Point: 429.8 °C at 760 mmHg; (13)Vapour Pressure: 3.76E-08 mmHg at 25°C

You can still convert the following datas into molecular structure:
(1)InChI=1S/2C17H23NO3.H2O4S/c2*1-18-13-7-8-14(18)10-15(9-13)21-17(20)16(11-19)12-5-3-2-4-6-12;1-5(2,3)4/h2*2-6,13-16,19H,7-11H2,1H3;(H2,1,2,3,4);
(2)InChIKey=HOBWAPHTEJGALG-UHFFFAOYSA-N;
(3)SmilesS(O)(O)(=O)=O.C1[C@@H](C[C@@H]2N([C@@H]1CC2)C)OC([C@@H](c1ccccc1)CO)=O.C1[C@@H](C[C@@H]2CC[C@@H]1N2C)OC([C@@H](c1ccccc1)CO)=O;

The toxicity data is as follows: